| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.06 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |